Area:
Cell Biology, Oncology
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Fritz F. Parl is the likely recipient of the following grants.
| Years |
Recipients |
Code |
Title / Keywords |
Matching
score |
| 2000 — 2004 |
Parl, Fritz F |
R01Activity Code Description:
To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
Mammary Estrogen Metabolism and Breast Cancer Risk
Mammary estrogen metabolism leads to the formation of catechol estrogens, the 2-OH and 4-OH derivatives of 17beta-estradiol (E2) and estrone (E1). These catechol estrogens can directly or indirectly induce DNA damage and have been implicated as a cause of breast cancer. The PI hypothesizes that differences in breast cancer risk between individuals are due in part to the individual-specific metabolism of catechol estrogens. In normal breast tissue and in breast tumors, catechol estrogens are produced by cytochromes P450 1A1 (CYP1A1) and 1B1 (CYP1B1) and are inactivated by catechol-O-methyltransferase (COMT). These enzymes exist as wild type forms and several polymorphic variants which may determine catechol estrogen exposures and resultant breast cancer risk in individual women. Aim 1 is to determine whether amino acid substitutions in CYP1A1, CYP1B1, and COMT affect estrogen metabolism using express recombinant forms of these enzymes. Aim 2 is to determine the effect of CYP1A1, CYP1B1, and COMT variant on estrogen metabolism in cultured cells, and to determine the relative inducibility of wild-type and variant forms of enzymes CYP1A1, CYP1B1, and COMT. Aim 3 is to determine the relationship between CYP1A1, CYP1B1, and COMT genotypes and catechol estrogen levels in benign and malignant human breast tissue. The applicants will measure catechol estrogens in tissues selected by genotype and matched by menopausal status and body mass index and compare the results to those in their in vitro and cell line experiments.
|
1 |